← Evidence map

TrialBreast cancer research and treatment2018

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.

Gabe S Sonke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

51 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 29058175